DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?

QR Code

DIABETES-ASSOCIATED OSTEOARTHRITIS: A SYNTROPY?

This review presents our own and literature data dedicated to predisposing and pathogenetic factors involved in development of a common comorbidity, diabetes-associated osteoarthritis (DAOA). So far, there is no wide-accepted clinical or scientific viewing of DAOA as a distinct clinical phenotype of...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. V. Kazygasheva, V. S. Shirinsky, I. V. Shirinsky
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2016-08-01
Series:	Медицинская иммунология
Subjects:	diabetes-associated osteoarthritis comorbidity type 2 diabetes osteoarthritis genetics immunopathogenesis
Online Access:	https://www.mimmun.ru/mimmun/article/view/1054
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

CLINICAL AND IMMUNOLOGICAL CHARACTERISTICS OF DIABETES-ASSOCIATED OSTEOARTHRITIS
by: I. V. Shirinsky, et al.
Published: (2015-03-01)

CLINICAL EFFICIENCY AND SAFETY OF FENOFIBRATE, A PPARα AGONIST, IN THE PATIENTS WITH DIABETESASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
by: V. S. Shirinsky, et al.
Published: (2017-05-01)

COMORBIDITY, DNA METHYLATION AND AUTOIMMUNITY IN DIABETES-ASSOCIATED OSTEOARTHRITIS: AN EXPLORATORY STUDY
by: I. V. Shirinsky, et al.
Published: (2015-10-01)

CLINICAL EFFICACY AND SAFETY OF ADEMETIONINE IN PATIENTS WITH DIABETES-ASSOCIATED OSTEOARTHRITIS: A CROSS-OVER PILOT STUDY
by: I. V. Shirinsky, et al.
Published: (2016-01-01)

INFLAMMATION AND IMMUNITY: A ROLE OF PATHOGENESIS OF OSTEOARTHRITIS
by: V. S. Shirinsky, et al.
Published: (2019-01-01)

The influence of type 2 diabetes mellitus on clinical manifestations of osteoarthritis
by: E. A. Taskina, et al.
Published: (2024-08-01)

Efficacy and safety of curcumin in patients with metabolic phenotype of osteoarthritis: A pilot study
by: I. V. Shirinsky, et al.
Published: (2023-06-01)

Perspectives of osteoarthritis prevention and therapy personification based on the analysis of comorbid background, genetic polymorphisms and microelement status
by: I. Yu. Torshin, et al.
Published: (2021-04-01)

Using Mendelian randomization analyses in osteoarthritis: state of art and future perspectives
by: Houpu Liu, et al.
Published: (2025-12-01)

Cardiovascular diseases and osteoarthritis: general mechanisms of development, prospects for combined prevention and therapy
by: M. A. Kabalyk, et al.
Published: (2021-02-01)

Expression of genes related to glucose metabolism and joint destruction in the development of diabetes mellitus in patients with osteoarthritis
by: E. V. Chetina, et al.
Published: (2019-03-01)

Study of efficiency of chondroitin-sulfate parenteral preparation in the therapy of recurrent chronic pain under osteoarthritis of knee-joints in comorbid patients
by: A. S. Sycheva, et al.
Published: (2021-06-01)

A prospective study on the effects of glucosamine hydrochloride and chondroitin sulfate combination on systemic inflammation markers in patients with knee osteoarthritis (report 1)
by: A. M. Lila, et al.
Published: (2025-06-01)

Combination treatment of patients with metabolic phenotype of osteoarthritis: an exploratory study
by: V. S. Shirinsky, et al.
Published: (2020-12-01)

The efficacy and safety of glycosaminoglycan-peptide complex in patients with knee osteoarthritis and comorbidity: a multicenter prospective study
by: L. I. Alekseeva, et al.
Published: (2021-02-01)

Diacerein in the treatment of osteoarthritis in patients with comorbidity
by: E. P. Sharapova, et al.
Published: (2018-12-01)

Pleiotropic effects of diacerein in comorbid patients with osteoarthritis
by: I. B. Belyaeva, et al.
Published: (2022-08-01)

Genetics of «atopic march» syntropy
by: E. Yu. Bragina, et al.
Published: (2020-11-01)

Disease-modifying osteoarthritis drugs (DMOADs): new trends in osteoarthritis therapy
by: O. A. Shavlovskaya, et al.
Published: (2023-11-01)

Etoricoxib for generalized osteoarthritis. Case report
by: I. S. Dydykina, et al.
Published: (2021-02-01)

Clinical and immunological features of metabolic phenotype of osteoarthritis
by: V. S. Shirinsky, et al.
Published: (2020-04-01)

OSTEOARTHRITIS AND DEPRESSION
by: N. I. Korshunov, et al.
Published: (2018-03-01)

Associations of physical activity with the risks of osteoarthritis and subtypes: a population-based cohort study of UK Biobank data
by: Huijie Gu, et al.
Published: (2025-07-01)

Early osteoarthritis: development of diagnostic criteria
by: L. I. Alekseeva, et al.
Published: (2020-09-01)

Modern achievements in pharmacotherapy of osteoarthritis based on endo- and phenotyping
by: I. V. Sarvilina, et al.
Published: (2021-10-01)

OSTEOARTHRITIS AND OBESITY
by: E. A. Strebkova, et al.
Published: (2015-10-01)

Alflutop in osteoarthritis therapy
by: G. V. Lukina, et al.
Published: (2004-06-01)

Frequency of detection and factors of elevated levels of diabetes-associated autoantibodies in the blood of patients with clinical type 2 diabetes mellitus
by: Y.A. Saienko, et al.
Published: (2025-04-01)

Study of the effectiveness of applying a double dose of ginger root extract for the treatment of osteoarthritis of the knee joints and hands
by: V.M. Kovalenko, et al.
Published: (2025-03-01)

Post hoc analysis of the results of KOLIBRI comparative observational clinical study in patients with knee and small hand joints osteoarthritis
by: A. Yu. Feklistov, et al.
Published: (2022-12-01)

STUDYING OF COMORBID PATHOLOGY AT THE 2 TYPES DIABETES AS THE COMPLICATION OF THE METABOLIC SYNDROME
by: S. P. Melikhova, et al.
Published: (2018-10-01)

Pharmacological therapy in patients with osteoarthritis and metabolic disorders: focus on diacerein
by: O.V. Kuryata, et al.
Published: (2025-03-01)

Experience in the use of a modern chondroprotector in patients with primary and secondary osteoarthritis of various localization in the acute stage
by: A. G. Khanov
Published: (2023-07-01)

Comorbidity profiles and treatment patterns of osteoarthritis patients in Beijing: A cross-sectional study based on community medical records
by: Zelu Zheng, et al.
Published: (2025-06-01)

Efficacy and safety of Chondroxide ointment in combine therapy of osteoarthritis patients
by: I. V. Kudrjavtzeva, et al.
Published: (2003-06-01)

Surveying the Role of Therapeutic Exercise in Knee and Hip Osteoarthritis: A Review study
by: Edris Bavardi Moghadam, et al.
Published: (2018-06-01)

THE SPECTRAL VARIABILITY OF THE SUBCHONDRAL BONE AT OSTEOARTHRITIS WITH COMORBIDITY
by: Maxim Alexandrovich Kabalyk
Published: (2022-10-01)

CLINICAL EFFICACY OF THE DRUG STRUCTUM IN OSTEOARTHRITIS THERAPY (results of multicenlral clinical study in Russia)
by: V A Nassonova, et al.
Published: (2001-04-01)

CHONDROPROTECTIVE DRUG ALFLUTOP IN THE TREATMENT OF OSTEOARTHRITIS
by: G V Lukina, et al.
Published: (2001-04-01)

Treatment Methods for Knee Osteoarthritis - A Literature Review
by: Oskar Tudaj, et al.
Published: (2025-06-01)